联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com
西亚试剂 —— 品质可靠,值得信赖
The type I TGF- receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino1,3, Noopur Thakur1,2,3, Susanne Grimsby1,3, Anders Marcusson1,2, Verena von Bulow1, Norbert Schuster1, Shouting Zhang1, Carl-Henrik Heldin1 & Maréne Landström1,2
Transforming growth factor- (TGF-
) is a multifunctional cytokine that regulates embryonic development and tissue homeostasis; however, aberrations of its activity occur in cancer1, 2. TGF-
signals through its Type II and Type I receptors (T
RII and T
RI) causing phosphorylation of Smad proteins3, 4. TGF-
-associated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, was originally identified as an effector of TGF-
-induced p38 activation5. However, the molecular mechanisms for its activation are unknown. Here we report that the ubiquitin ligase (E3) TRAF6 interacts with a consensus motif present in T
RI. The T
RI–TRAF6 interaction is required for TGF-
-induced autoubiquitylation of TRAF6 and subsequent activation of the TAK1–p38/JNK pathway, which leads to apoptosis. T
RI kinase activity is required for activation of the canonical Smad pathway, whereas E3 activity of TRAF6 regulates the activation of TAK1 in a receptor kinase-independent manner. Intriguingly, TGF-
-induced TRAF6-mediated Lys 63-linked polyubiquitylation of TAK1 Lys 34 correlates with TAK1 activation. Our data show that TGF-
specifically activates TAK1 through interaction of T
RI with TRAF6, whereas activation of Smad2 is not dependent on TRAF6.